SCHEMBL16893092

SCHEMBL16893092

CNc1ncc(C)c(-c2c[nH]c(OC(=O)NCCc3cccnc3)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 1/20 0.41
▸ NAMPT P43490 3/20 0.39
▸ PTGFR P43088 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ PTAFR P25105 1/20 0.39
▸ AURKA O14965 4/20 0.38
▸ CDK2 P24941 3/20 0.38
▸ MAPK1 P28482 3/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ INSR P06213 1/20 0.37
▸ IGF1R P08069 1/20 0.37
▸ FGFR1 P11362 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ FLT3 P36888 1/20 0.37
▸ CHRM4 P08173 1/20 0.36
▸ PDK1 Q15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16893141 0.89 NAMPT (0.40) GSK3BNAMPTPTGFRNPC1RAB9A
SCHEMBL16892977 0.86 AKT3 (0.46) GSK3BAURKACDK2HDAC2HDAC8
SCHEMBL16893145 0.79 AURKA (0.51) AURKACDK2MAPK1JAK2FLT3
SCHEMBL16893116 0.78 NAMPT (0.38) GSK3BNAMPTPTGFRMAPK1HDAC2
SCHEMBL16893017 0.77 ADORA1 (0.46) GSK3BNAMPTPTGFRPTAFRCDK2
SCHEMBL16893078 0.77 GSK3B (0.47) GSK3BNAMPTPTGFRNPC1RAB9A
SCHEMBL16893094 0.76 AURKA (0.54) AURKACDK2MAPK1JAK2FLT3
SCHEMBL16893075 0.75 MELK (0.45) GSK3BNPC1RAB9AMAPK1
SCHEMBL16893031 0.74 AURKA (0.57) AURKACDK2MAPK1FLT3
SCHEMBL16893088 0.74 AURKA (0.52) AURKACDK2MAPK1HDAC6JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363906-B1 HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF VERTEX PHARMA (US) 2015-07-15 — — EP claimed
Send feedback